Furthermore, it has been shown that IL-18 blockade, by using either neutralizing anti-murine IL-18 antiserum [187] or by the administration of an adenovirus expressing IL-18 antisense mRNA [188], diminishes inflammation in murine models of colitis. This evidence concerns the gene IL18 and colitis.